Vogenx

Exited, —

Public biopharmaceutical company developing mizagliflozin for metabolic and gastrointestinal diseases. Its October 2026 release announced initiation of the EMERGE Phase 2b study.

At a glance

HQ: Raleigh
Sector: Biotech

See the full company record.

Founders, funding history and recent signals. Free accounts open immediately.

We don’t have a confirmed role to show at Vogenx.

If you want to work here anyway, tell us what you are after and Adam will pass it to the Vogenx team when there is a real fit.

Listed roles

All Triangle roles

Checking listed roles…